Why Are Pliant Therapeutics Shares Rallying Today?
Pliant Therapeutics Inc’s (NASDAQ:PLRX) Phase 2a trial of PLN-74809 in patients with idiopathic pulmonary fibrosis (IPF) met its primary and…
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
Innoviva Inc (NASDAQ:INVA) has agreed to acquire La Jolla Pharmaceutical Company (NASDAQ:LJPC) for $5.95 per share, representing a premium of approximately 70%…
Arcutis Biotherapeutics Announces Health Canada Accepts For Review New Drug Submission For Roflumilast Cream For Adults And Adolescents With Plaque Psoriasis
Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as well as results from long-term safety studies
If approved, roflumilast cream would be the first and
FDA Clears LPCN 2101 IND For Adult Epilepsy Treatment
Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company focused on developing innovative products to treat metabolic and central nervous system ("CNS") disorders with high unmet medical needs, announced
Abbott Reopens Its Michigan Plant Closed Due To Floods: Report
Abbott Laboratories (NYSE:ABT) has reopened its Sturgis, Michigan, baby formula plant, which was shut last month due to heavy…
Can-Fite To Submit FDA & EMA Registration Plans For Piclidenoson In The Oral Treatment Of Moderate To Severe Psoriasis
Further analysis of Phase III COMFORT™ data show Piclidenoson's superior safety profile and higher patient compliance compared to Otezla®
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CFBI), a
Patient Death Prompts MacroGenics To Close Mid-Stage Head & Cancer Study
MacroGenics Inc (NASDAQ:MGNX) closed the Phase 2 study (CP-MGA271-06) of enoblituzumab in the first-line treatment of patients with recurrent or metastatic…
Autoliv Partners With POC For Bicycle Helmets With Airbag
Autoliv Inc (NYSE:ALV) collaborates with snow sports and cycling protection provider POC to develop bicycle and e-bike helmets with airbag technology.…
Shinzo Abe’s Alleged Killer Honed His Gunmaking Skills On YouTube, Tested Weapon At Religious Facility
The man who allegedly shot dead former Prime Minister of Japan, Shinzo Abe, learned to make guns by watching videos on Alphabet Inc's (NASDAQ: GOOGL) (NASDAQ: GOOG) Youtube and
Putin Could Use Nukes If This Captured Town Is Taken Back By Ukraine, Says Former Russian Opposition Figure
Russia’s President Vladimir Putin would be ready to use nuclear weapons in case Ukraine attempts to recover a key territory, according to an expert.